Frontiers in Immunology· 2026Q1
Disease-modifying therapies are associated with improved olfactory function via NK cell- microbiota interactions in multiple sclerosis
- 0citations
- Q1SCImago
- 2026year
Short summary
Disease-modifying therapies (DMTs) in multiple sclerosis (MS) patients are associated with improved olfactory function, potentially mediated by interactions between NK cells and nasal microbiota.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Sensory Systems
Sensory SystemsNeuroscience